The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Moseley Ken since 2015.
The trader's CIK number is 1626895.
At the time of the last reporting, Moseley Ken was the Sr. VP and General Counsel of Bellicum Pharmaceuticals, Inc. (stock ticker symbol BLCM).
Also see all insider trading activities at Bellicum Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | BLCM | 0 | $0 | 0 | $0 | 1,563 | $0 |
| 2017 | BLCM | 0 | $0 | 13,823 | $169,469 | 13,823 | $35,248 |
| 2016 | BLCM | 0 | $0 | 30,000 | $496,215 | 30,000 | $150,300 |
| 2015 | BLCM | 0 | $0 | 30,000 | $509,415 | 30,000 | $76,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-03 | BLCM | Option Ex | 1,563 | .00 | 0 |
| 2017-07-13 | BLCM | Option Ex | 13,823 | 2.55 | 35,248 |
| 2017-07-13 | BLCM | Sale | 13,823 | 12.26 | 169,469 |
| 2016-09-21 | BLCM | Option Ex | 100 | 7.47 | 747 |
| 2016-09-23 | BLCM | Sale | 11,700 | 20.10 | 235,193 |
| 2016-09-23 | BLCM | Option Ex | 11,700 | 7.47 | 87,399 |
| 2016-09-21 | BLCM | Sale | 100 | 20.04 | 2,004 |
| 2016-09-19 | BLCM | Sale | 1,300 | 20.01 | 26,018 |
| 2016-09-20 | BLCM | Sale | 200 | 20.00 | 4,000 |
| 2016-09-16 | BLCM | Option Ex | 700 | 7.47 | 5,229 |
| 2016-09-16 | BLCM | Sale | 700 | 20.00 | 14,000 |
| 2016-09-19 | BLCM | Option Ex | 1,300 | 7.47 | 9,711 |
| 2016-09-20 | BLCM | Option Ex | 200 | 7.47 | 1,494 |
| 2016-08-15 | BLCM | Option Ex | 1,000 | 7.47 | 7,470 |
| 2016-08-15 | BLCM | Sale | 1,000 | 20.00 | 20,000 |
| 2016-06-02 | BLCM | Sale | 15,000 | 13.00 | 195,000 |
| 2016-06-02 | BLCM | Option Ex | 15,000 | 2.55 | 38,250 |
| 2015-11-02 | BLCM | Option Ex | 15,000 | 2.55 | 38,250 |
| 2015-11-02 | BLCM | Sale | 15,000 | 13.00 | 195,000 |
| 2015-07-01 | BLCM | Option Ex | 15,000 | 2.55 | 38,250 |
| 2015-07-01 | BLCM | Sale | 15,000 | 20.96 | 314,415 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moseley Ken (Sr. VP and General Counsel of Bellicum Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.